Weifan Zheng

Dr. Weifan Zheng serves as an Associate Professor in the Department of Pharmaceutical Sciences at North Carolina Central University (NCCU), bringing extensive industry experience from GlaxoSmithKline (GSK) and Eli Lilly in computational drug discovery and data sciences. His academic foundation includes a Ph.D. in Pharmaceutical Sciences from UNC's Eshelman School of Pharmacy with specialization in chemical biology and medicinal chemistry.

Education:

• Ph.D. in Pharmaceutical Sciences, UNC Eshelman School of Pharmacy

His research integrates artificial intelligence, machine learning, and biomedical knowledge graphs to pioneer innovative drug repurposing strategies and novel therapeutic development. Current collaborative initiatives span cancer drug discovery with Drs. KP Williams and John Scott, neurodegeneration research with Drs. Ibeanu and Andy Li, and health disparity projects with Dr. Kumar, reflecting his commitment to translational science across multiple disease domains.

Dr. Zheng maintains active research partnerships with UNC-Chapel Hill and the Renaissance Computing Institute (RENCI), though specific grant details and student advising records are not documented in available materials.

His work operates within interdisciplinary research teams focused on computational pharmacology, leveraging institutional collaborations to address complex challenges in drug discovery and health equity.